Does intensive blood pressure control provide similar benefits without an increased risk of serious adverse events in patients with frailty compared to other patients?
Intensive blood pressure control is safe and effective for frail patients with high cardiovascular risk, extending the known benefits of the SPRINT trial to this vulnerable subgroup.
Frailty status was a marker of high cardiovascular risk. Patients with frailty benefit similarly to other patients from intensive blood pressure control without an increased risk of serious adverse events.
Wang et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: